Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Medullary thyroid carcinoma (MTC) and papillary thyroid carcinoma (PTC) are both associated with mutations of the RET protooncogene. In MTC, these are activating point mutations which may occur somatically, in sporadic tumours, or in the germline, in the case of multiple endocrine neoplasia type 2 (MEN 2). In PTC, somatic rearrangements of RET result in the expression of a chimeric oncoprotein with transforming potential. In this study, we investigated a family including two members with bilateral-multifocal MTC, suggesting a diagnosis of MEN 2, co-occurring with multiple cases of PTC. We showed that a point mutation of RET codon 618 is present in the two family members with MTC but is absent in those with PTC. No rearrangements of RET were detected in any family members. We conclude that the MTC and PTC observed in this family do not arise from the same RET mutation. © 1999, by Walter de Gruyter GmbH & Co. All rights reserved.

Original publication




Journal article


International Journal on Disability and Human Development

Publication Date





27 - 32